Icariside II, a phosphodiesterase 5 inhibitor, attenuates cerebral ischemia/reperfusion injury by inhibiting GSK-3β-mediated activation of autophagy.
Cerebral ischemia/reperfusion (I/R) is always exacerbated neuronal damage when timely restoring cerebral blood flow after ischemia stroke. Cerebral I/R results in excessive autophagy and neuronal demise. The present study was designed to explore the role of autophagy during ICS II-mediated neuroprotection on cerebral I/R in vivo and in vitro. The rat focal cerebral ischemia was induced 2 h of transient middle cerebral artery occlusion (MCAO) followed by reperfusion with ICS II, 3-MA or Rapamycin. The effect of ICS II was detemined using neurological behaviour and cerebral infarction. The expressions of phosphodiesterase 5 (PDE 5), autophagy-related proteins and phosphorylation levels of GSK-3β were determined. Primary rat cortical neurons were subjected to oxygen and glucose deprivation and reoxygenation (OGD/R) were applied to further elucidate the mechanism of ICS II on cerebral (I/R). A surface plasmon resonance assay and molecular docking were used to explore the interactions of ICS II with PDE 5 or GSK-3β. ICS II not only protected against MCAO-induced injury in rats, but also attenuated primary cortical neurons injury upon OGD/R. The neuroprotective effects of ICS II on cerebral I/R were attributed to mediating PKG/GSK-3β/autophagy axis. ICS II directly bound to PDE 5 and GSK-3β, and there also existed the interaction between PKG and GSK-3β. These findings indicate that ICS II attenuates cerebral I/R-induced injury via mediating PKG/GSK-3β/autophagy axis. This study will raise the possibility that ICS II may be exploited into a potent PDE 5 inhibitor against ischemia stroke.